Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Arteriosclerosis, Thrombosis, and Vascular Biology|August 15, 2024
Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase InhibitorsRichard J Travers, Alec Stepanian, Iris Z JaffeCritical Reviews in Biochemistry and Molecular Biology|May 29, 2015
How it all starts: Initiation of the clotting cascadeStephanie A Smith, Richard J Travers, James H MorrisseyBlood|July 3, 2015
FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flowShu Zhu, Richard J Travers, James H Morrissey, et al.JACC. Case Reports|July 11, 2025
Permissive Cardiotoxicity and Determination of Anthracycline Risk With Previous Anthracycline ExposureRichard J Travers, Nicholas Camarda, Iris Z Jaffe, et al.Blood|September 10, 2014
Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasisRichard J Travers, Rajesh A Shenoi, Manu Thomas Kalathottukaren, et al.Blood|September 13, 2012
Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammationStephanie A Smith, Sharon H Choi, Julie N R Collins, et al.Plos One|November 20, 2023
Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitorsYihua Wang, Richard J Travers, Alanna Farrell, et al.Research and Practice in Thrombosis and Haemostasis|September 23, 2024
Antipolyphosphate monoclonal antibodies derived from autoimmune miceJosepha C Sedzro, Stephanie A Smith, Alexander Scott, et al.Circulation|August 5, 2025
Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and StrokeAlec Stepanian, Richard J Travers, Angelina Tesfu, et al.Blood|June 25, 2016
Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitorLakshmi C Wijeyewickrema, Emilie Lameignere, Lilian Hor, et al.Pageof 2